3D Printing

Analyst Comment

The potential of 3D printing in drug development and delivery

3D printing will be extensively adopted across various aspects of healthcare in the next ten years.

Strategic Intelligence

News

Aspect wins $72.75m from Canadian government for bioprinted pipeline

Features

3D printing in drug manufacturing: unlocking future possibilities

Analyst Comment

3D Printing in Healthcare: Macroeconomic Trends

News

Real-world evidence the most impactful emerging technology in COVID-19 management: Poll

Features

Turning pharma green: an eco-wish list for the industry

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Sections

The potential of 3D printing in drug development and delivery

Aspect wins $72.75m from Canadian government for bioprinted pipeline

3D printing in drug manufacturing: unlocking future possibilities

3D Printing in Healthcare: Macroeconomic Trends

Real-world evidence the most impactful emerging technology in COVID-19 management: Poll

Turning pharma green: an eco-wish list for the industry

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading Artificial Intelligence (AI) Companies in Pharma

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief